Division of Pharmacotherapy and Experimental Therapeutics welcomes two team members

July 12, 2019

Two new faculty members joined the UNC Eshelman School of Pharmacy’s Division of Pharmacotherapy and Experimental Therapeutics on July 1. Get to know Benyam Muluneh, Pharm.D., BCOP, CPP, and Klarissa Jackson, Ph.D.: Q: What is your hometown?      Benyam: Addis Ababa, Ethiopia      Klarissa: Tyler, Texas Q: What are you looking forward to about your new role?      Benyam: I am looking forward to contributing to the teaching and scholarship missions at the School with the ultimate goal of improving the lives of patients. I am excited about collaborators and mentors within the Eshelman School of Pharmacy in … Continued


UNC Eshelman School of Pharmacy Selects New Dean

May 30, 2019

The UNC Eshelman School of Pharmacy has selected Angela Kashuba, B.Sc.Phm., Pharm.D., DABCP, FCP, to be the next dean of the School. Kashuba, who currently chairs the School’s Division of Pharmacotherapy and Experimental Therapeutics (DPET), will assume her new position as dean on October 1, pending final approval by the University’s Board of Trustees. “It has been my great honor to be a part of the UNC Eshelman School of Pharmacy and I am thrilled to have the opportunity to build upon the School’s success and culture of innovation,” Kashuba said. “I look forward to working with our brilliant students, … Continued


Kim Brouwer honored as Inventor of the Year

May 24, 2019

UNC Eshelman School of Pharmacy’s Kim L. R. Brouwer, Pharm.D., Ph.D., was distinguished as Inventor of the Year during the 2019 UNC Celebration of Inventorship, on May 23. During the celebration, the UNC Office of Technology Commercialization presents the Inventor of the Year Award to a UNC-Chapel Hill innovator in recognition of their contributions to inventions and patents. The award honors the recipient’s commitment to the University’s culture of encouraging innovation, disseminating knowledge and promoting entrepreneurship. Brouwer is the William R. Kenan Jr. Distinguished Professor in the Division of Pharmacotherapy and Experimental Therapeutics at the UNC Eshelman School of Pharmacy, … Continued


Beaudoin, Vogt Earn NIH Predoctoral Research Grants

March 27, 2019

Two Ph.D. candidates at the UNC Eshelman School of Pharmacy recently received National Research Service Awards from the National Institutes of Health. Jim Beaudoin, from the Division of Pharmacotherapy and Experimental Therapeutics, and Caleb Vogt, from the Division of Chemical Biology and Medicinal Chemistry, received the NRSA grants. Beaudoin is advised by Kim Brouwer, Pharm.D., Ph.D., and Vogt is advised by Jeff Aubé, Ph.D. The NIH grant, known also as an F31, is awarded to promising predoctoral students so that they can obtain individualized, mentored research training while conducting dissertation research. Beaudoin’s research project will investigate organic solute transporter α/β, … Continued


UNC Study Reveals Precision Oncology Insights for Colorectal Cancer

March 25, 2019

Next-generation sequencing of tumor DNA from patients with colorectal cancer revealed genetic alterations that were linked to different survival and treatment outcomes in an analysis led by a researcher at the UNC Eshelman School of Pharmacy. The findings, published in the Journal of Clinical Oncology, could help define strategies to more effectively treat colorectal cancer, the second leading cause of cancer death in the United States. “This is an example of precision oncology, where using genetics, we are able to stratify tumor types that we once believed were homogeneous, and to identify new patient subgroups that might benefit from tailored therapies,” … Continued


Martin, Hanafin Win Presidential Trainee Awards from ASCPT

March 4, 2019

Two students from the UNC Eshelman School of Pharmacy were awarded the Presidential Trainee Award from the American Society for Clinical Pharmacology and Therapeutics. Jesse Martin and Patrick Hanafin were among the 17 recipients of the award, which recognizes the top scoring abstracts submitted by clinical pharmacologists in training. Martin also received the ASCPT Jason Morrow Trainee Award for the second-highest scoring trainee abstract submitted. The award includes a $1,000 prize. Both students will be recognized and receive their awards at the ASCPT Annual Meeting in March in Washington, DC. Martin is a third-year Pharm.D. student in the Research and … Continued


Jackie Gerhart Wins BAHM Case Competition

February 27, 2019

Jackie Gerhart, a Ph.D. student at the UNC Eshelman School of Pharmacy, took first place at the Business School Alliance for Health Management Case Competition at Harvard Business School on Feb. 9. Gerhart and her partner, Aditi Borde, a dual MHA/MBA candidate, won a $10,000 first place prize for their pitch idea for a partnership with Walmart and Blue Cross Blue Shield NC to develop an incentivized diabetes management program for rural communities. Gerhart is a Ph.D. candidate under the supervision of Daniel Gonzalez, Pharm.D., Ph.D., an assistant professor in the Division of Pharmacotherapy and Experimental Therapeutics. Nearly 40 students … Continued


Paavo Honkakoski Receives Keohane Professorship

February 25, 2019

Paavo Honkakoski, Ph.D., a global expert on nuclear receptors, will return to the UNC Eshelman School of Pharmacy as a recipient of the Nannerl O. Keohane Distinguished Visiting Professorship in 2019-20. Honkakoski is a professor of Biopharmacy at the School of Pharmacy and Faculty of Health Sciences at the University of Eastern Finland. The Keohane Professorship is designed to promote collaboration and the enhancement of intellectual life between UNC-Chapel Hill and Duke University, with an emphasis on contributions to the teaching missions of both universities. Past recipients have catalyzed cross-campus undergraduate and graduate programs, conducted joint projects with Carolina and … Continued


Gonzalez Receives $2M NIH Grant for Project on Childhood Obesity

October 9, 2018

Daniel Gonzalez, Pharm.D., Ph.D., an assistant professor at the UNC Eshelman School of Pharmacy in the Division of Pharmacotherapy and Experimental Therapeutics, received a $2 million NIH Research Project Grant for research focused on drug dosing in children with obesity. Gonzalez’s proposal aims to find a systematic approach to the development and evaluation of physiologically-based pharmacokinetic models to help treat children with obesity. These models are mathematical constructs that incorporate physiologic and body composition changes during childhood. “The majority of drugs prescribed to children with obesity lack recommendations for appropriate dosing for size,” Gonzalez said. “Physiologically-based pharmacokinetic models can be used … Continued


Crona Awarded ACCP Research Institute Futures Grant

September 24, 2018

Daniel Crona, Pharm.D., Ph.D., an assistant professor at the UNC Eshelman School of Pharmacy in the Division of Pharmacotherapy and Experimental Therapeutics, was awarded the American College of Clinical Pharmacy Research Institute Futures Grant Junior Investigator Award. Crona received the award and a $30,000 grant from the ACCP Research Institute for his proposal, “A Prospective Multi-Dose Study of Apixaban in Nephrotic Syndrome Patients.” “Currently, there is no established standard of care prophylactic for venous thromboembolic events in nephrotic syndrome patients,” Crona said. “However, direct oral anticoagulants, apixaban in particular, are appealing options for thromboprophylaxis. There is an unmet need to … Continued